Full-Time

Product Marketing Manager

Epigenetics & Developmental Biology

Cell Signaling Technology

Cell Signaling Technology

1,001-5,000 employees

Antibody development and validated research tools

Compensation Overview

$138k - $189k/yr

+ 401(k) match of 6%

Danvers, MA, USA

In Person

Onsite role based in the Danvers, Massachusetts office.

Master's, PhD

Category
Biology & Biotech (1)
Required Skills
Market Research
Lead Generation
Social Media
Data Analysis

Get referred to Cell Signaling Technology

See people who can refer or advise you

Requirements
  • A Master's degree in a related life science area such as Genetics, Developmental Biology, or Cancer Biology.
  • At least 5 years of experience in product marketing or a related role in the life sciences industry.
  • Experience managing a reagent product line with demonstrated success.
  • Experience working with global sales channels and distributors.
Responsibilities
  • Create and implement strategic product marketing plans covering product differentiation, value, pricing, channel strategy, portfolio support, product launches, customer acquisition, and revenue growth.
  • Develop product positioning and messaging for multiple customer segments, including academia, biopharma, and contract research or development and manufacturing organizations.
  • Establish frameworks and metrics to measure product-launch success, including adoption rates, customer feedback, and sales performance.
  • Design and execute integrated marketing campaigns to drive product adoption, protect market share, and expand into new markets.
  • Oversee the creation and ongoing maintenance of product content, including web content, collateral, whitepapers, webinars, case studies, and blogs.
  • Collaborate with marketing communications and channel owners to use multimedia, social media, and digital marketing strategies to increase portfolio awareness and generate qualified leads.
  • Collaborate with regional marketing teams to localize campaigns and align them with market-specific strategies.
  • Integrate voice-of-customer feedback into campaign strategies.
  • Partner with sales teams to develop and deliver training, tools, and resources that communicate product benefits and value propositions.
  • Align marketing initiatives with sales strategies to optimize lead generation, pipeline velocity, and revenue growth.
  • Lead regular training sessions for sales and customer-facing teams.
  • Support distributors and e-commerce platforms with targeted resources and programs.
  • Conduct market research to identify industry trends, customer pain points, and competitive offerings.
  • Use market insights to identify opportunities and threats and inform pricing strategies, product roadmaps, and differentiation tactics.
  • Develop market segmentation and customer personas from data-driven insights.
  • Provide recommendations to improve market share and customer satisfaction using continuous product-performance analysis.
  • Partner with research and development and strategic marketing teams to develop and execute a roadmap for the reagent antibody portfolio.
  • Build business cases for portfolio expansion, including market opportunity assessments and revenue projections.
  • Define key performance indicators and success metrics for product marketing campaigns and initiatives.
  • Use analytics to monitor product performance, market share, and campaign results, and report insights to senior leadership.
  • Collaborate with strategic marketing, product management, marketing communications, sales, and research and development teams on product development and marketing initiatives.
  • Partner with regional sales teams on product positioning, sales enablement, and sales-tool development.
  • Engage operations, regulatory, and customer support teams to ensure product quality, compliance, and a seamless customer experience.
Desired Qualifications
  • A PhD in a related life science area such as Genetics, Developmental Biology, or Cancer Biology.
  • Experience with Pragmatic or similar marketing frameworks.
Cell Signaling Technology

Cell Signaling Technology

View

Cell Signaling Technology (CST) provides antibodies and related research products for scientists, especially in cancer research. Its main offering is antibodies that are thoroughly validated for multiple experimental applications, ensuring reliability across experiments. CST’s antibodies are produced by Ph.D.-level scientists who also deliver technical guidance and support to researchers to help achieve dependable results. The company differentiates itself through its strong emphasis on validation, quality control, and hands-on scientific support from its own researchers, operating with a family-owned, research-institute mindset rather than purely as a generic supplier. CST’s goal is to help researchers obtain accurate, reproducible data by supplying validated antibodies and expert methods guidance for use in the lab.

Company Size

1,001-5,000

Company Stage

N/A

Total Funding

N/A

Headquarters

Danvers, Massachusetts

Founded

1999

Get referred to Cell Signaling Technology

See people who can refer or advise you

Simplify Jobs

Simplify's Take

What believers are saying

  • Quantum-Si and CST partnered June 2026 to validate PTM analysis on Proteus.
  • CST and MJFF are developing Parkinson's antibodies, expanding disease-targeted reagent demand.
  • Nordic Biosite began exclusive Nordic distribution for CST G4S Linker antibodies in August 2026.

What critics are saying

  • CST sells research-use-only reagents; a single validation miss destroys trust fast.
  • Spatial-biology rivals compress CST's mid-plex advantage as panels standardize.
  • If citation leadership fades, CST's antibody brand moat collapses and pricing power erodes.

What makes Cell Signaling Technology unique

  • CST remains scientist-owned and runs a 600-plus employee antibody platform from Danvers.
  • CiteAb named CST 2026 Phospho Antibody Supplier of the Year.
  • CST pairs validated antibodies with SignalStar multiplex IHC and PTM analysis partnerships.

Help us improve and share your feedback! Did you find this helpful?

Benefits

Health Insurance

Dental Insurance

Vision Insurance

Life Insurance

Disability Insurance

401(k) Company Match

Tuition Reimbursement

Unlimited Paid Time Off

Parental Leave

Employee Assistance Program

Professional Development Budget

Growth & Insights and Company News

Headcount

6 month growth

27%

1 year growth

27%

2 year growth

27%
Nordic Biosite
Aug 19th, 2026
Nordic Biosite is the exclusive Nordic distributor for CST's G4S Linker Rabbit Monoclonal antibodies.

Nordic Biosite is the exclusive Nordic distributor for CST's G4S Linker Rabbit Monoclonal antibodies. news August 19 2026 Nordic Biosite is excited to announce its exclusive distribution partnership across Sweden, Denmark, Norway, and Finland for Cell Signaling Technology's (CST) premier line of Pre-GMP-grade G4S Linker antibodies. Chimeric Antigen Receptor (CAR) cell therapy is moving at a rapid pace, but researchers often struggle with reliable tracking reagents during early-phase development. This exclusive partnership changes that by bringing CST's premier translational tools directly to the Nordic region. Nordic Biosite is fully authorized to distribute the following early-access, Pre-GMP-grade products: * G4S Linker (E7O2V) Rabbit Monoclonal Antibody (PE Conjugate) * G4S Linker (E7O2V) Rabbit Monoclonal Antibody (Biotin Conjugate) By keeping these high-demand reagents in local stock, Nordic Biosite eliminates long international shipping delays, ensuring your lab has immediate access to the exact tools you need to advance your cell therapy research. News & articles. News August 13 2026 News July 31 2026 News June 30 2026 News August 19 2026 News August 18 2026 News August 13 2026 News July 31 2026 News June 30 2026 News August 19 2026 News August 18 2026

BioSpace
Mar 26th, 2025
Leveragen Partners with Cell Signaling Technology to Advance Reagent Antibody Innovation with Proprietary Nanobody Technology

Leveragen partners with Cell Signaling Technology to advance reagent antibody innovation with proprietary nanobody Technology.

Cell Signaling Technology
Feb 12th, 2025
Does It Really Work? How InTraSeq(TM) Integrates Transcriptomic, Proteomic, & Intracellular Interaction Data

Cell Signaling Technology, Inc. is thrilled to announce the winners of the 5th annual Rising Black Scientists Awards!

Cell Signaling Technology
Oct 24th, 2023
Cell Signaling Technology and The Michael J. Fox Foundation Partner to Develop High-Quality Antibody Tools for Parkinson's Disease Research

Cell Signaling Technology (CST), a life science discovery technology company and leading provider of antibodies, kits, and services, announced their partnership with The Michael J. Fox Foundation for Parkinson's Research (MJFF) today to identify and develop high-quality monoclonal antibodies for promising Parkinson's disease (PD) targets.

Compsmag
Sep 20th, 2023
Green Chemistry Education: Cell Signaling Technology and Beyond Benign Join Forces for a Sustainable Future!

According to a recent announcement, Cell Signaling Technology (CST), a prominent life sciences discovery technology company, has partnered with Beyond Benign, a global green chemistry education nonprofit.